Publication | Open Access
The real-world use and effectiveness of avacopan in routine practice for the treatment of ANCA vasculitis. First experiences in Spain
14
Citations
14
References
2024
Year
The combination of avacopan with standard immunosuppressive therapy presents a good safety profile and provides added value by contributing to the control of AAV activity, increase GFR and removal of steroids.
| Year | Citations | |
|---|---|---|
Page 1
Page 1